Pearce, Ian
Amoaku, Winfried http://orcid.org/0000-0001-5028-7984
Bailey, Clare http://orcid.org/0000-0003-2141-4512
Downey, Louise
Gale, Richard
Ghanchi, Faruque http://orcid.org/0000-0002-4448-8162
Hamilton, Robin
Mahmood, Sajjad
Menon, Geeta
Nosek, Jenny
Talks, James http://orcid.org/0000-0001-6126-6476
Yang, Yit http://orcid.org/0000-0002-5392-5133
Article History
Received: 26 November 2021
Revised: 24 January 2022
Accepted: 22 February 2022
First Online: 21 March 2022
Competing interests
: WA has received research grants from Allergan, Bayer, CentreVue, Boerhinger Ingelheim, Novartis; Educational travel grants from Alimera, Allergan, Bayer, Novartis and honoraria for Advisory Board Memberships from Abbvie, Alimera, Allergan, Bayer, Novartis, and Roche. CB has received grant funding for advisory board work /travel support from Novartis, Bayer, Roche, Bristol Eye Hospital and has received research funding from Bayer, Novartis, Allergan, Boehringer–Ingelheim, and Roche. LD has received research funding from Allergan, Bayer, Novartis, Alimera, Roche, educational travel grants from Allergan, Bayer, Novartis and Honoraria for Advisory Boards/speakers fees from Alimera, Bayer, Novartis, Roche, Bausch and Lomb. RG has conducted consultancy-advisory boards for Novartis, Bayer and Allergan, Alimera, Santen, received educational travel grants from Novartis, Bayer, Allergan, Heidelberg and departmental research from Allergan, Bayer, Novartis, and Roche. FG has received honorarium for consultancy-advisory boards from Alimera, Allergan, Bayer, Novartis, Oxford BioElectronics, Roche; educational travel grants from Allergan, Bayer, Novartis and departmental research grants from Allergan, Bayer, Boehringer Ingelheim, Chengdu Pharma, Novartis, PanOptica, Roche. RH has received non-financial assistance, personal fees, and been advisor to Novartis, Bayer, Allergan, Roche, and Ellex. SM has received lecture fees from Bayer and Novartis, consultancy fees from Alimera, Bayer, Novartis, Travel fees from Bayer and Novartis and Research funding from Bayer, Novartis and Roche. GM has conducted consultancy-advisory boards for Novartis, Bayer and Allergan, received educational travel grants from Novartis, Bayer, Allergan; and departmental research from Allergan, Bayer, Boehringer Ingelheim, Chengdu Pharma, Novartis, PanOptica, and Roche. JN has received honorarium from Novartis, Bayer and Zeiss. YY has received personal fees and non-financial assistance from Novartis, Bayer, Allergan, and Roche. IP has received lecture fees from Allergan, Bayer, Heidelberg and Novartis, consultancy fees from Allergan, Alimera, Bayer and Novartis and travel fees from Allergan, Bayer and Novartis.